project id: TCGA-LUAD; case submitter id: TCGA-MP-A4TI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.5; age at index: 72; days to birth: -26565; days to death: 429; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1938; year of death: 2011; age at diagnosis: 26565; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.917808219178082; pack years smoked: 35.0; years smoked: 35.0; is ffpe: false; composition: Not Reported; days to collection: 780; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-MP-A4TI-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 8.0; percent tumor cells: 92.0; percent tumor nuclei: 60.0;